| Customization: | Available |
|---|---|
| CAS No.: | 231277-92-2, Customization |
| Formula: | C181h291n55o51s 2, Customization |
|
Still deciding? Get samples of US$ 400/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Introduction:
Lapatinib (trade name: Tykerb) is an oral chemotherapy medication used in the treatment of certain types of cancer. It is approved for use in combination with other drugs for patients with advanced or metastatic breast cancer that is HER2-positive, meaning it overexpresses a protein called human epidermal receptor 2 (HER2).
Lapatinib works by inhibiting the activity of the HER2 protein, which is responsible for promoting the growth and division of cancer cells. By blocking this protein, Lapatinib helps to slow down the growth of cancer cells and can improve the effectiveness of other anticancer treatments.
Function:
In terms of its efficacy, clinical studies have shown that Lapatinib, when used in combination with other chemotherapy agents, can significantly prolong the progression-free survival in patients with HER2-positive breast cancer. It has demonstrated positive results in both early-stage and advanced-stage breast cancer patients.
Application:
Lapatinib is typically administered orally in the form of tablets. It is important to follow the prescribed dosage and any additional instructions provided by the healthcare provider. Common side effects may include diarrhea, nausea, fatigue, skin rash, and changes in liver function.
1. Are you a manufacturer or trading company?
A: We are a manufacturer and welcome to visit our factory.
){kind=link}